Annual Reports on Medicinal Chemistry

Inbunden, Engelska, 2026

Del 66 i serien Annual Reports in Medicinal Chemistry

2 196 kr

Kommande

Beskrivning

Annual Reports in Medicinal Chemistry Volume 66 provides timely and critical reviews of important topics in medicinal chemistry, with an emphasis on emerging topics in the biological sciences that are expected to provide the basis for entirely new future therapies. Focus in this new release is on The anti-inflammatory and immunological properties of GLP-1R and How to reduce side effects of GLP-1 based obesity medications.

Contains contributions from leading authorities on the topics covered
Informs and updates on all the latest developments in the field of medicinal chemistry
Delves into the use of GLP-1s and side effect reduction

Produktinformation

Utgivningsdatum:2026-10-01
Mått:152 x 229 x undefined mm
Vikt:450 g
Format:Inbunden
Språk:Engelska
Serie:Annual Reports in Medicinal Chemistry
Antal sidor:310
Förlag:Elsevier Science
ISBN:9780443472541

Utforska kategorier

Farmakologi inom Medicin
Kemi inom Naturvetenskap och teknik
Organisk kemi inom Naturvetenskap och teknik

Mer om författaren

Prof. Katherine Seley-Radtke group’s NIH-funded research employs a chemical biology approach tonucleoside, nucleotide and heterocyclic drug discovery and development with therapeuticemphasis on antiviral, anticancer and antiparasitic targets and overcoming resistance to currentlyused drugs. Current focus is targeting Ebola, Zika, Dengue and MERS viruses. She has served asthe Program Director for UMBC’s Chemistry-Biology Interface graduate training programfunded by NIH since 2007. This program promotes hands on cross disciplinary research foralmost 50 PhD students from four departments at UMBC and UMB. She is currently theImmediate Past President and Secretary-Elect for the International Society of Nucleosides,Nucleotides and Nucleic Acids and a Board member of the International Society for AntiviralResearch. Prof. Seley-Radtke also serves as a standing member for several NIH study sectionsand is an Associate Editor for three scientific journals – Antiviral Chemistry & Chemotherapy,Molecules – Chemical Biology, and Current Protocols in Chemical Biology.

Innehållsförteckning

1: The anti-infiammatory and immunological properties of GLP-1R2: GLP-1–based multipharmacology: biased signaling as a determinant of therapeutic efficacy3: How to reduce side effects of GLP-1 based obesity medications